Your browser doesn't support javascript.
loading
Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer.
Takano, Yuko; Furune, Satoshi; Miyai, Yuki; Morita, Sachi; Inoue, Megumi; Shimokata, Tomoya; Sugishita, Mihoko; Mitsuma, Ayako; Maeda, Osamu; Ando, Yuichi.
Afiliação
  • Takano Y; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Furune S; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Miyai Y; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Morita S; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Inoue M; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Shimokata T; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Sugishita M; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Mitsuma A; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Maeda O; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
  • Ando Y; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.
Int Cancer Conf J ; 11(1): 67-70, 2022 Jan.
Article em En | MEDLINE | ID: mdl-35116219

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article